Ziconotide for Non-cancer Pain by Intrathecal Administration

RecruitingOBSERVATIONAL
Enrollment

85

Participants

Timeline

Start Date

October 30, 2024

Primary Completion Date

October 30, 2029

Study Completion Date

October 30, 2029

Conditions
Pain, Chronic
Interventions
DRUG

Ziconotide [Prialt]

Intrathecal injection of ziconotide, using an internal pump, surgically inserted by a trained neurosurgeon or anesthesiologist, under general anesthesia.

Trial Locations (14)

Unknown

RECRUITING

Clinique de la Casamance, Aubagne

RECRUITING

Hospices Civils de Lyon, Bron

NOT_YET_RECRUITING

Polyclinique du Parc, Caen

RECRUITING

CHD Vendée, La Roche-sur-Yon

RECRUITING

CH Laon, Laon

RECRUITING

CHU Lille, Lille

RECRUITING

Clinique Mutualiste de la Porte de l'Orient, Lorient

RECRUITING

Centre Léon Bérard, Lyon

NOT_YET_RECRUITING

Hopital Saint Joseph, Paris

NOT_YET_RECRUITING

CHU Poitiers, Poitiers

NOT_YET_RECRUITING

CHU Reims, Reims

RECRUITING

CH Yves Le foll, Saint-Brieuc

RECRUITING

CHU St Etienne, Saint-Etienne

NOT_YET_RECRUITING

IUCT Toulouse, Toulouse

Sponsors
All Listed Sponsors
lead

ESTEVE Pharmaceuticals SAS

INDUSTRY